Clinical Trial Update: Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing celecoxib to prevent polyps after surgery for stage I colon cancer in colorectal cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer | Phase 3 | Status: TERMINATED